Sleep Restriction and Energy Expenditure

August 1, 2013 updated by: St. Luke's-Roosevelt Hospital Center

The Effect of Sleep Reduction on Daily Energy Expenditure, Thermic Effect of Food, and Substrate Oxidation in Overweight Women

Each 4-day period will follow the same protocol. Basically, for the entire study, we will prepare all of the subject's food and will require him or her to eat all of the food that we give at the times we tell them to eat. The subject will arrive at the hospital on the evening of day 1, and become inpatients. On day 2, the subject will be permitted to leave the hospital campus under the supervision of the research staff. On day 3, they will be required to stay in a small room called a metabolic chamber for 24 hours. This room measures how many calories you burn in one day. On day 4, we will measure the subject's energy expenditure in response to a breakfast meal. They will be given breakfast and the number of calories that they burn after that meal will be measured over a 6-hour period. Then the subject will be discharged at the end of the test. The 2 study periods will differ only in bedtimes and wakeup times. During one period, the subject will go to bed at 1 am and wake up at 5 am and during the other period they will go to bed at 11 pm and wake up at 7 am.

Study Overview

Status

Completed

Conditions

Detailed Description

Sleeping metabolic rate will be measured using a metabolic chamber on the night of day 2. During day 3, 24-hour energy expenditure (including a second night of measurement) will be measured in the metabolic chamber. On this day, the participant will perform 2 bouts of physical activity on a stationary bicycle for 15 minutes each bout. This will give us a measurement of physical activity energy expenditure. On day 4, at 7 am, the participant will exit the metabolic chamber and will enter a different, smaller metabolic chamber for the measurement of energy expenditure in response to a meal. This measurement will start at approximately 8 am with assessment of the resting metabolic rate (45 minutes). The participant will then be given a high-fat meal replacement to consume over 10 minutes. Energy expenditure measurements continue in the metabolic chamber for a 6-hour period.

Study Type

Interventional

Enrollment (Anticipated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10026
        • St. Luke's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Age 21-45 yrs
  • Non-pregnant, non-lactating female subjects
  • Body mass index (BMI) 25-28 kg/m2
  • Weight stable (± 2.5 kg) for at least 3 mo prior to evaluation
  • If a woman of child-bearing potential, must be willing to adhere to an acceptable form of contraception
  • Non-smoker
  • Regularly sleeps 7-8.5 hours/night
  • If taking any form of medication, other than those listed in the exclusion criteria, must have been stable and remain on the same medication and medication dose throughout the study

Exclusion Criteria:

  • Diabetes, uncontrolled hypertension
  • Attempted to lose weight in past 3 months
  • Eating disorder
  • Stroke, seizure disorder, or other significant neurological disease;
  • HIV positive by self-report
  • Unstable or uncontrolled medical illness including active malignancies within past 5 yrs
  • Untreated or unstable hypothyroidism
  • Hyperthyroidism
  • A score on the Brief Psychiatric Inventory that exceeds the 90th percentile;
  • Subjects with psychoses, bipolar disorder, major depression, severe personality disorders, suicidal
  • Alcohol or substance abuse in the past 6 mo
  • Pregnant, planning pregnancy in the next 6 mo, or breast-feeding
  • Participating in a commercial diet or behavior modification program (e.g., Weight Watchers), or plans to participate
  • Shift worker, commercial long-distance driver, heavy equipment operator, history of drowsy driving
  • Takes naps regularly
  • Has traveled across time zones in the past 4 weeks or plans to during the weeks of the study
  • Excessive caffeine intake

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Habitual Sleep
Women sleep 8 h/night throughout the study phase
Participants sleep 8 h/night throughout the study phase (from 11 pm to 7 am)
Experimental: Short Sleep
Women sleep 4 h/night throughout the study phase
Participants will be restricted in sleep and only allowed to sleep from 1 am to 5 am.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Resting Metabolic Rate
Time Frame: 32 hours
Metabolic rate from 11 pm on day 2 until 7 am on the morning of day 4 will be measured in a metabolic chamber. The metabolic chamber is an air-tight room (22,000 l volume) equipped with a bed, chair, desk, television, VCR, telephone, treadmill, sink and toilet. All meals and snacks will be served at the scheduled time. Subjects will be asked to perform 30 min of light physical activity at 1500 h and 2030 h. Physical activity will consist of 30 min of cycling at 12 mi/h. Bedtimes will be the same as the previous night and actigraph monitoring will be used to confirm compliance with the sleep protocol. Women will exit the chamber at 0700 h the following day.
32 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post Prandial Energy Expenditure and Thermic Effect of Food
Time Frame: 8 hours on day 4

Energy expenditure will be measured from 8 am until approximately 2:30 pm on day. Resting metabolic rate over 45 minutes will be measured at 8 am, followed by breakfast and resumption of energy expenditure measurements postprandially.

Participants will be given 15 min to consume a high-fat breakfast (50% of energy from fat) and post-prandial thermogenesis and substrate oxidation will be measured for the next 6 h.

8 hours on day 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marie-Pierre St. Onge, PhD, St. Luke's Roosevelt Hospital/Columbia University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2011

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

April 1, 2013

Study Registration Dates

First Submitted

June 6, 2012

First Submitted That Met QC Criteria

December 13, 2012

First Posted (Estimate)

December 18, 2012

Study Record Updates

Last Update Posted (Estimate)

August 2, 2013

Last Update Submitted That Met QC Criteria

August 1, 2013

Last Verified

December 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • SLR-P&F-1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Habitual sleep

3
Subscribe